ACR supports patients' access to treatments act of 2013

February 12, 2013
ACR supports patients' access to treatments act of 2013
The American College of Rheumatology has joined the Coalition for Accessible Treatments, in support of the Patients' Access to Treatments Act of 2013, which will reduce the out-of-pocket expenses for medications, including biologics.

(HealthDay)—The American College of Rheumatology (ACR) has joined the Coalition for Accessible Treatments, in support of the Patients' Access to Treatments Act of 2013, which will reduce the out-of-pocket expenses for medications, including biologics.

Noting that some are placing biologics in "specialty tiers," which require patients to pay 20 to 50 percent of , Rep. David B. McKinley (R-WV) and Rep. Lois Capps (D-Calif.) have reintroduced legislation to limit cost-sharing requirements for medications placed in these tiers, increasing accessibility by decreasing excessive out-of-pocket expenses.

The Patients' Access to Treatments Act of 2013 is supported by the Coalition for Accessible Treatments, which is encouraging patients and physicians to ask lawmakers to support and cosponsor the act. The American College of Rheumatology is one of 18 member organizations that have joined the coalition.

"Biologics are essential tools used to fight the progression of and prevent disability," Audrey Uknis, M.D., president of the American College of Rheumatology, said in a statement. "The ACR is encouraged that Reps. McKinley and Capps have reintroduced this important bill and continue to advocate that patients with should have access to live-saving treatments."

Explore further: No difference in death rates among patients exposed to common rheumatoid arthritis drugs

More information: More Information

Related Stories

No difference in death rates among patients exposed to common rheumatoid arthritis drugs

August 8, 2012
New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), ...

Newer, more expensive psoriasis drugs only slightly more effective than older therapies under real world conditions

April 30, 2012
More expensive biologic treatments for psoriasis were only marginally more effective than standard treatments, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania. ...

ACR updates guidelines for use of DMARDs and biologic drugs in treating rheumatoid arthritis

April 2, 2012
The American College of Rheumatology (ACR) has released the 2012 recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) and biologic agents in the treatment of rheumatoid arthritis (RA). The guidelines ...

American College of Rheumatology releases first classification criteria for polymyalagia rheumatica

March 2, 2012
The American College of Rheumatology has released the first classification criteria for polymyalgia rheumatica – aimed at helping physicians identify patients with this condition, which occurs in persons aged 50 years ...

ACR in Choosing Wisely campaign to promote wise use of resources among physicians and patients

December 14, 2011
As part of its ongoing efforts to ensure safe, effective and appropriate medical imaging, the American College of Radiology has joined the ABIM Foundation and eight other medical specialty societies in Choosing Wisely. The ...

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.